Effects of COVID-19 on Medical Resources
The pandemic has left the healthcare system with staffing and revenue shortages, as well as supply chain management challenges, that are expected to extend into the foreseeable future.
Study Shows COVID-19 Infection Correlates with Autoimmune Markers
A new study demonstrates how severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) infection could be associated with an autoimmune response and development of autoantibodies.
Transition from Clinic- to Home-Based IVIG/SCIG Is Successful to Decrease Exposure to COVID-19
Transition of clinic-based to home-based intravenous immune globulin (IVIG)/subcutaneous IG (SCIG) infusion can be successfully done to decrease potential exposure during a pandemic in a high-risk immunosuppressed population.
Researchers Theorize Long COVID May Be an Autoimmune Disease
The National Institutes of Health is conducting a $470 million study to determine why COVID-19 symptoms persist for so long among many patients.
IVIG Plus Glucocorticoids Effective for Treating COVID-19 Pediatric Syndrome
A large multicenter clinical trial has found intravenous immune globulin (IVIG) plus glucocorticoids may be better than IVIG alone for treating multisystem inflammatory syndrome in children (MIS-C) caused by COVID-19.
Studies Reveal Antibody Responses of Pregnant Women Infected with SARS-CoV-2
Two recent studies effectively determined the antibody responses of pregnant women infected with SARS-CoV-2 and the effect of the fetal sex on those responses, as well as the direct clinical implications for COVID-19 infection and future maternal-fetal vaccination strategies.
CMS Launches New Medicare.gov Tool to Compare Nursing Home Vaccination Rates
The Centers for Medicare & Medicaid Services (CMS) is making it easier to check COVID-19 vaccination rates for nursing home staff and residents by making vaccination data available in a user-friendly format.
HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding
The U.S. Department of Health and Human Services (HHS) is making $25.5 billion in new funding available for healthcare providers affected by the COVID- 19 pandemic.
OCR Issues Guidance on HIPAA, COVID-19 Vaccinations and the Workplace
The U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) issued guidance to help the public understand when the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule applies to disclosures and requests for information about whether a person has received a COVID-19 vaccine.
Universal Flu Vaccines Advance from Concept to Clinical Trials
“Scientists have identified components of the influenza virus that do not really change muchat all. The critical challenge is getting a vaccine to induce a response to those components.”
— Anthony Fauci, MD, Director, National Institute of Allergy and Infectious Diseases